Literature DB >> 23573895

Hydroxychloroquine-induced phospholipidosis in a case of SLE: the wolf in zebra clothing.

Shaila Raju Khubchandani1, Lata Sunil Bichle.   

Abstract

A 30 year old lady patient of SLE on steroid and hydroxychloroquine therapy presented with lupus nephritis and later developed cardiac symptoms. Her renal biopsy revealed features of Class III lupus nephritis. Also seen was typical lamellated myelinoid material in the glomerulus. The alpha-galactosidase A activity was normal. The clinical morphological and biochemical findings were consistent with Lupus nephritis showing changes of hydroxychloroquine induced phopholipidosis. Electron microscopy along with careful clinical examination and follow up status was instrumental in the diagnosis of the latter.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23573895     DOI: 10.3109/01913123.2012.751950

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  4 in total

1.  Hydroxychloroquine-induced podocytopathy mimicking Fabry disease.

Authors:  Justine Serre; David Buob; Jean-Jacques Boffa
Journal:  BMJ Case Rep       Date:  2019-05-13

2.  Can HCQ Be Considered a "Safe Weapon" for COVID-19 in the Indian Population?

Authors:  Pugazhenthan Thangaraju; Nanditha Venkatesan; Sajitha Venkatesan; Meenalotchini Prakash Gurunthalingam; Eswaran Thangaraju
Journal:  SN Compr Clin Med       Date:  2020-07-10

Review 3.  Lupus nephritis.

Authors:  Hans-Joachim Anders; Ramesh Saxena; Ming-Hui Zhao; Ioannis Parodis; Jane E Salmon; Chandra Mohan
Journal:  Nat Rev Dis Primers       Date:  2020-01-23       Impact factor: 52.329

4.  Ultrastructural deposits appearing as "zebra bodies" in renal biopsy: Fabry disease?- comparative case reports.

Authors:  Precil Diego Miranda de Menezes Neves; Juliana Reis Machado; Fabiano Bichuette Custódio; Maria Luíza Gonçalves Dos Reis Monteiro; Shigueo Iwamoto; Marlene Freire; Marisa França Ferreira; Marlene Antônia Dos Reis
Journal:  BMC Nephrol       Date:  2017-05-12       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.